Medlive Technology Co., Ltd.

SEHK:2192 Rapporto sulle azioni

Cap. di mercato: HK$6.6b

Medlive Technology Performance dei guadagni passati

Il passato criteri di controllo 4/6

Medlive Technology ha registrato una crescita degli utili a un tasso medio annuo di 47.3%, mentre il settore Healthcare Services ha registrato utili in crescita a un tasso medio annuo di 13%. I ricavi sono stati in crescita a un tasso medio annuo di 20.9%. Il ritorno sul capitale proprio di Medlive Technology è 6.4% e ha margini netti di 60.2%.

Informazioni chiave

47.3%

Tasso di crescita degli utili

39.8%

Tasso di crescita dell'EPS

Healthcare Services Crescita del settore22.3%
Tasso di crescita dei ricavi20.9%
Rendimento del capitale proprio6.4%
Margine netto60.2%
Ultimo aggiornamento sui guadagni30 Jun 2024

Aggiornamenti sulle prestazioni recenti

Investors Shouldn't Be Too Comfortable With Medlive Technology's (HKG:2192) Earnings

Oct 02
Investors Shouldn't Be Too Comfortable With Medlive Technology's (HKG:2192) Earnings

Recent updates

Investors Shouldn't Be Too Comfortable With Medlive Technology's (HKG:2192) Earnings

Oct 02
Investors Shouldn't Be Too Comfortable With Medlive Technology's (HKG:2192) Earnings

Pinning Down Medlive Technology Co., Ltd.'s (HKG:2192) P/E Is Difficult Right Now

Sep 27
Pinning Down Medlive Technology Co., Ltd.'s (HKG:2192) P/E Is Difficult Right Now

Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

Jul 04
Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

Medlive Technology Co., Ltd.'s (HKG:2192) Business Is Yet to Catch Up With Its Share Price

Apr 08
Medlive Technology Co., Ltd.'s (HKG:2192) Business Is Yet to Catch Up With Its Share Price

Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Feb 20
Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Are Medlive Technology Co., Ltd. (HKG:2192) Investors Paying Above The Intrinsic Value?

Jan 10
Are Medlive Technology Co., Ltd. (HKG:2192) Investors Paying Above The Intrinsic Value?

Medlive Technology Co., Ltd.'s (HKG:2192) Intrinsic Value Is Potentially 20% Below Its Share Price

Sep 27
Medlive Technology Co., Ltd.'s (HKG:2192) Intrinsic Value Is Potentially 20% Below Its Share Price

Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Jul 10
Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Medlive Technology Co., Ltd. (HKG:2192) Shares Slammed 28% But Getting In Cheap Might Be Difficult Regardless

May 11
Medlive Technology Co., Ltd. (HKG:2192) Shares Slammed 28% But Getting In Cheap Might Be Difficult Regardless

Robust Earnings May Not Tell The Whole Story For Medlive Technology (HKG:2192)

May 02
Robust Earnings May Not Tell The Whole Story For Medlive Technology (HKG:2192)

Results: Medlive Technology Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Mar 26
Results: Medlive Technology Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Here's What's Concerning About Medlive Technology's (HKG:2192) Returns On Capital

Feb 06
Here's What's Concerning About Medlive Technology's (HKG:2192) Returns On Capital

There Are Reasons To Feel Uneasy About Medlive Technology's (HKG:2192) Returns On Capital

Oct 31
There Are Reasons To Feel Uneasy About Medlive Technology's (HKG:2192) Returns On Capital

Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

Jul 14
Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

These Analysts Just Made A Massive Downgrade To Their Medlive Technology Co., Ltd. (HKG:2192) EPS Forecasts

Apr 03
These Analysts Just Made A Massive Downgrade To Their Medlive Technology Co., Ltd. (HKG:2192) EPS Forecasts

Is Medlive Technology Co., Ltd. (HKG:2192) Worth HK$9.5 Based On Its Intrinsic Value?

Feb 22
Is Medlive Technology Co., Ltd. (HKG:2192) Worth HK$9.5 Based On Its Intrinsic Value?

Ripartizione dei ricavi e delle spese

Come Medlive Technology guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.


Storia dei guadagni e delle entrate

SEHK:2192 Ricavi, spese e utili (CNY Millions )
DataRicaviGuadagniSpese G+ASpese di R&S
30 Jun 244822901960
31 Mar 244472661870
31 Dec 234122421770
30 Sep 233842161670
30 Jun 233561891580
31 Mar 233351531550
31 Dec 223141171510
30 Sep 22300831430
30 Jun 22286481350
31 Mar 22285441310
31 Dec 21284411280
30 Sep 21270551090
30 Jun 2125570890
31 Mar 2123478710
31 Dec 2021485530
31 Dec 1912231370
31 Dec 188314310

Guadagni di qualità: 2192 ha un livello elevato di guadagni non monetari.

Margine di profitto in crescita: Gli attuali margini di profitto netti di 2192 (60.2%) 2192 sono più alti rispetto allo scorso anno (53.2%).


Flusso di cassa libero e analisi degli utili


Analisi della crescita degli utili nel passato

Andamento degli utili: Gli utili di 2192 sono cresciuti in modo significativo del 47.3% all'anno negli ultimi 5 anni.

Accelerare la crescita: La crescita degli utili di 2192 nell'ultimo anno ( 53.5% ) supera la media quinquennale ( 47.3% all'anno).

Guadagni vs Settore: La crescita degli utili 2192 nell'ultimo anno ( 53.5% ) ha superato la percentuale del settore Healthcare Services 11.9%.


Rendimento del capitale proprio

ROE elevato: Il Return on Equity ( 6.4% ) di 2192 è considerato basso.


Rendimento delle attività


Rendimento del capitale investito


Scoprire le aziende con forti performance passate